Literature DB >> 18494838

Cannabis potency and contamination: a review of the literature.

Jennifer McLaren1, Wendy Swift, Paul Dillon, Steve Allsop.   

Abstract

AIMS: Increased potency and contamination of cannabis have been linked in the public domain to adverse mental health outcomes. This paper reviews the available international evidence on patterns of cannabis potency and contamination and potential associated harms, and discusses their implications for prevention and harm reduction measures.
METHODS: A systematic literature search on cannabis potency and contamination was conducted.
RESULTS: Cannabis samples tested in the United States, the Netherlands, United Kingdom and Italy have shown increases in potency over the last 10 years. Some countries have not shown significant increases in potency, while other countries have not monitored potency over time. While there are some grounds to be concerned about potential contaminants in cannabis, there has been no systematic monitoring.
CONCLUSION: Increased potency has been observed in some countries, but there is enormous variation between samples, meaning that cannabis users may be exposed to greater variation in a single year than over years or decades. Claims made in the public domain about a 20- or 30-fold increase in cannabis potency and about the adverse mental health effects of cannabis contamination are not supported currently by the evidence. Systematic scientific testing of cannabis is needed to monitor current and ongoing trends in cannabis potency, and to determine whether cannabis is contaminated. Additionally, more research is needed to determine whether increased potency and contamination translates to harm for users, who need to be provided with accurate and credible information to prevent and reduce harms associated with cannabis use.

Mesh:

Substances:

Year:  2008        PMID: 18494838     DOI: 10.1111/j.1360-0443.2008.02230.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  42 in total

1.  Setting the baseline: a description of cannabis poisonings at a Canadian pediatric hospital prior to the legalization of recreational cannabis.

Authors:  Phoebe Cheng; Atousa Zagaran; Fahra Rajabali; Kate Turcotte; Shelina Babul
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-06       Impact factor: 3.240

2.  Marijuana Induced Myocarditis: A New Entity of Toxic Myocarditis.

Authors:  Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Navneet Singh; Teresa Song; Stanley Soroka; Abhimanyu Amarnani; Justina Ray; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-09-26

3.  Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report.

Authors:  Masayuki Nogi; David Fergusson; John Michael Chua Chiaco
Journal:  Hawaii J Med Public Health       Date:  2014-04

4.  Medical marijuana users in substance abuse treatment.

Authors:  Ronald Swartz
Journal:  Harm Reduct J       Date:  2010-03-05

5.  Persistent cannabis users show neuropsychological decline from childhood to midlife.

Authors:  Madeline H Meier; Avshalom Caspi; Antony Ambler; HonaLee Harrington; Renate Houts; Richard S E Keefe; Kay McDonald; Aimee Ward; Richie Poulton; Terrie E Moffitt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

Review 6.  Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews.

Authors:  Paul Posadzki; Leala Watson; Edzard Ernst
Journal:  Eur J Clin Pharmacol       Date:  2012-07-29       Impact factor: 2.953

7.  Long-term consequences of adolescent cannabis use: Examining intermediary processes.

Authors:  Kerry M Green; Elaine E Doherty; Margaret E Ensminger
Journal:  Am J Drug Alcohol Abuse       Date:  2016-12-08       Impact factor: 3.829

8.  The effects of medical marijuana laws on potency.

Authors:  Eric L Sevigny; Rosalie Liccardo Pacula; Paul Heaton
Journal:  Int J Drug Policy       Date:  2014-01-18

9.  A 10-year review of cannabis exposure in children under 3-years of age: do we need a more global approach?

Authors:  Isabelle Claudet; Mathilde Le Breton; Camille Bréhin; Nicolas Franchitto
Journal:  Eur J Pediatr       Date:  2017-02-16       Impact factor: 3.183

10.  Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

Authors:  Anna Buadze; Rudolf Stohler; Beate Schulze; Michael Schaub; Michael Liebrenz
Journal:  Harm Reduct J       Date:  2010-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.